Finally, a significant reduction in tumor development was observed in the group of mice vaccinated with IFN-treated Usp18+/- cells, as assessed by the gold standard vaccination assay in B16F10 and MC38 tumor mouse models. This evidence concerns the gene IFNA1 and neoplasm.